Physicochemical Properties and Analytical Methods of Determination of Biguanides

  • E. Prugnard
  • M. Noel
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 119)

Abstract

As described by Shapiro et al. (1959), biguanides are diacid bases. They have a particularly strong primary dissociation constant and a considerably weaker second dissociation constant. The first salts of biguanides which were prepared were the sulfate (obtained by treatment of the biguanide-copper complex), the hydrochloride and the nitrate because of its insolubility. Other known salts are the toluenesulfonate, the tartrate and the pamoate. In order to obtain a better pharmacological activity some other salts have been prepared by treating biguanides with carboxylic acids. These salts were the adamantate, Clofibrate, orotate, nicotinate, isoxazole-carboxylate, pyrazole-carboxylate, trimethoxybenzoate and 4-chlorophenoxyacetate.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alkalay D, Volk J, Bartlett MF (1976) Conversion of biguanides into substituted triazines assayable by GC or mass fragmentography. J Pharm Sci 65:525–529PubMedCrossRefGoogle Scholar
  2. Alkalay D, Khermani L, Bartlett MF (1978) Radioimmunoassay determination of p-hydroxyphenformin and of apparent phenformin in human plasma and serum. Anal Lett Bll (9):741–751Google Scholar
  3. Amigo JM, Martinez-Calatayud J (1985) Molecular structure of the phenylbiguanide hydrochloride. Bull Soc Chim Belg 94:119–121CrossRefGoogle Scholar
  4. Audry E, Dubost JP, Colleter JC, Dallet P (1986) Eur J Med Chem Chim Ther 21:71–72Google Scholar
  5. Bandyapadhaya DN, Gosh NN, Ray P. (1952) Stability of chromium (III) biguanide and chromium (III) phenyl biguanide complexes. J Indian Chem Soc 29:157–168Google Scholar
  6. Beckamnn R (1971) Biguanide. In: Maske H (ed) Ornl Wirksame Antidiabetika Springer, Berlin Heidelberg New York, pp 439–596 (Handbook der experimen teilen Pharmakologie, vol 29)CrossRefGoogle Scholar
  7. Bellenger P, Hamon M, Mahuzier G (1983) Synthèse et propriétés spectrales de guanamines substitues utilisables pour la Chromatographie des biguanides. Ann Pharm Fr 41(4):327–337PubMedGoogle Scholar
  8. Benzi L, Marchetti P Cecchetti P, Navalesi R (1986) Determination of metformin and phenformin in human plasma and urine by reversed-phase high performance liuid chromatography. J Chromatogr 375:184–189Google Scholar
  9. Boyer F. (1984) Pharmacocinétique de la Metformine chez l’homme. Doctoral Dissertation, Montpellier UniversityGoogle Scholar
  10. Bres J, Bressolle F, Huguet MT (1976) Importance de la dissociatin ionique des médicaments en pharmacocinétique. Méthode de détermination de leur pKa. Trav Soc Pharm Montpellier 36(4):331–364Google Scholar
  11. Brohon J, Noël M (1978) Determinatio of metformin in plasma at therapeutic levels by gas liquid chromatography using a nitrogen detector. J Chromatogr 146(I):148–151PubMedGoogle Scholar
  12. Brown CJ (1967) The crystal structure of l-(p-chlorophenyl-5-isopropylbiguanide (Paludine). J Chem Soc A:60–65Google Scholar
  13. Brown CJ, Sengier L (1984) l-(p-Chlorophenyl) biguanide hydrochloride. Acta Crystallogr C 40:1294–1295Google Scholar
  14. Charles BG, Jacobsen NW, Ravenscroft PJ. (1981) Rapid liquid chromatographic determination of metformin in plasma and urine. Clin Chem 27(3):434–436PubMedGoogle Scholar
  15. Das Sarma B (1952) Acid dissociation constants and basicity of biguanides and dibiguanides. J Indian Chem Soc 29:217–224Google Scholar
  16. De AK, Ghosh NN, Ray P (1950) Stability of cobaltic biguanide complexes. J Indian Chem Soc 27:493–508Google Scholar
  17. Dornboos DA (1967) The determination of the acid dissociation constants of L-cysteine, D-penicillamine, N-acetyl D-penicillamine and some biguanides by an accurate method for pH measurement. Pharm Weekbl 102:269–287Google Scholar
  18. Dutta RL, Sengupta R (1961) Acid dissociation constants of the N’ substituted biguanides and dibiguanides. J Indian Chem Soc 38:741–746Google Scholar
  19. El Khateeb SZ, Assaad HN, El Bardicy MG, Ahmad AS (1988) Determination of metformin hydrochloride in tablets by nuclear magnetic resonance spectrometry. Anal Chim Acta 208:321–324CrossRefGoogle Scholar
  20. Ernst SR (1977) Biguanide hydrochloride. Acta Cryst allogr B 33:237–240CrossRefGoogle Scholar
  21. Ernst SR, Cagle Jr FW (1977) Biguanide. Acta Cryst allogr B 33:235–237CrossRefGoogle Scholar
  22. Fanshawe WJ, Bauer VJ, Ullman EF, Safir SR (1964) Synthesis of unsymmetrically substituted malnamidimes. J Org Chem 29(2):308–311CrossRefGoogle Scholar
  23. Fuerst W, Schmidt A, Stuetz B (1982) Problems of high-pressure liquid chromatography after derivatization. Wiss Z Ernst-Moritz-Arndt-Univ Greifsw Math-Naturwiss Reihe 31(2):49–50Google Scholar
  24. Gage JC (1949) Synthetic antimalarials. Part XXXIV. Physicochemical studies on the diguanides. J Chem Soc:221–226Google Scholar
  25. Garrett ER, Tsau J (1972) Application of ion-pair methods to drug extraction from biological fluids. I. Quantitative determination of biguanides in urine. J Pharm Sci 61(9):1404–1410PubMedCrossRefGoogle Scholar
  26. Garrett ER, Tsau J, Hinderlign PH (1972) Application of ion-pair methods to drug extraction from biological fluids. II. Quantitative determination of bgiuanides in biological fluids and comparison of proteins binding estimates. J Pharm Sci 61(9):1411–1418PubMedCrossRefGoogle Scholar
  27. Goizman MS, Sarkisyan SO, Sarkysian AA, Persianova IV (1985) Differential spectrophotometric determination of biguanide derivatives. Pham Chem J 19:503–508Google Scholar
  28. Handa R, Saha N (1973) Crystal and molecular structures of morpholine biguanide hydrobromide. Acta Crystallog:544–568Google Scholar
  29. Hariharan M, Rajan SS, Srinivasan R (1989) Structure of metformn hydrochloride. Acta Crystallog C 45(6):911–913CrossRefGoogle Scholar
  30. Herrnstadt C, Mootz D, Wunderlich H (1979) Protonation sites of orgaic bases with several nitrogen functions: crystal structures of salts of chlrodiazepoxide dihy-dralazine and phenformin. J Chem Soc Perkin Trans 11:735–740Google Scholar
  31. Heuclin C, Pene F, Savouret JF, Assan R (1975) Characterization of phenformin and metabolites in plasma. Diabète et Métabolismè; 1:235–240Google Scholar
  32. Hill HM, Chamberlain J (1978) Determination of oral anitdiabetic agents in human body fluids using high-performance liquid chromatography. J Chromatogr 149:349–358PubMedCrossRefGoogle Scholar
  33. Hirt RC, Schmitt RG (1958) Ultraviolet absorption spectra of derivatives of striazine. II. Oxotriazines and their acyclin analogs. Spectrochim Acta 12:127–138CrossRefGoogle Scholar
  34. Huuponen R, Ojala-Karlsson P, Rouru J, Koulu M (1992) Determination of metformin in plasma by high performance liquid chromatography. J Chromatogr Biomed Appl 583:270–273CrossRefGoogle Scholar
  35. Jung L, Wermuth CG, Morand P (1961) Identification and determination of synthetic hypoglycemic agents in urine. Travaux Soc Pharm Montpellier 21:170–175Google Scholar
  36. Keal J, Somogyi A (1986) Rapid and sensitive high-performance liquid chromatographic assay for metformin in plasma and urine using ion-pair extraction techniques. J Chromatogr 378:503–508PubMedGoogle Scholar
  37. Kobayashi Y, Kubo H, Kinoshita T (1988) Fluorimetric determination of biguanides in serum by high-performance liquid chromatography with reagent containing mobile phase. J Chromatogr 430:65–71PubMedGoogle Scholar
  38. Koji Nakanishi (1962) Infrared absorption spectroscopy. Holden-Day, San FranciscoGoogle Scholar
  39. Kurzer F, Pitchfork ED (1968) The chemistry of biguanides. Fortschr Chem Forsch 10:375–472CrossRefGoogle Scholar
  40. Lacroix C, Danger P, Wojciechowski F (1991) Microdosage de la metformine plasmatique et intra-erythrocytaire par Chromatographie en phase liquide. Ann Biol Clin (Paris) 49:98–101Google Scholar
  41. Lennard MS, Casey C, Trucker GT, Woods HF (1978) Determination of metformin in biological samples. Br J Clin Pharmacol 6(2): 183–184PubMedCrossRefGoogle Scholar
  42. Matin SB, Karam JH, Forsham PF (1975) Simple electron capture gas chromatographic method for the determination of oral hypoglycemic biguanides in biological fluids. Anal Chem 47(3):545–548PubMedCrossRefGoogle Scholar
  43. Martinez-Calatayud JM, Sampedro AS (1989) Turbimetric determination of phenformin by flow-injection analysis. Analysis 17:413–416Google Scholar
  44. Mottale M, Stewart CJ (1975) Gas chromatographic determinatilon of β-phenethyl-biguanide and its metabolite p-hydroxy β-phenethylbiguanide in serum and urine. J Chromatogr 106:263–270PubMedCrossRefGoogle Scholar
  45. Nandi SD (1972) Spectrophotometric (UV) investigation on biguanide and substituted biguanides. Tetrahedron 28(3):845–853CrossRefGoogle Scholar
  46. Oates NS, Shah RR, Idle JR, Smith RL (1980) On the urinary dispositin of phenformin and 4-hydroxy-phenformin and their rapid simultaneous measurement. J Pharm Pharmacol 32(10):731–732PubMedCrossRefGoogle Scholar
  47. Oetting F (1975) Radioimmuological determination of n-butylbiguanide in human serum. Arznei Forsch 25(4):524–526Google Scholar
  48. Oetting F (1982) Radioimmunoassay of n-butylbiguanide. Methods Enzymol 84: 577–585CrossRefGoogle Scholar
  49. Ovsepyan AM, Fialkova MA, Mikhailova NV, Kobyskov VV, Kochkina SN, Belai VE, Panov VP (1984) Spectrophotometric determination of N,N-dimethylbiguanide hydrochloride. Pharm Chem J 18:366–368Google Scholar
  50. Pignard P (1962) Dosage spectrophotométrique du NN dimethylbiguanide dans le sang et l’urine. Ann Biol Clin (Paris) 20:325–333Google Scholar
  51. Predescu I, Moisescu S, Cenuse M (1989) Adaptation of a color reaction to the quantitative determinatio of buformin tosylate Farmacia (Bucharest) 37(l):45–52Google Scholar
  52. Ross MSF (1977) Determination of metformin in biological fluids by derivatization followed by high-performance liquid chromatography. J Chromatogr 133: 408–411PubMedCrossRefGoogle Scholar
  53. Sastry CSP, Rao T, Sailaya A (1991) Spectrophotometric determination of phenformin hydrochloride in dosage forms. Indian Drugs 28(8):378–379Google Scholar
  54. Shapiro SL, Parrino VA, Freedman AL (1959) Hypoglycemic agents. I. Chemical properties of β-phenethylbiguanide. New hypoglycemc agent. J Am Chem Soc 81:2220–2225CrossRefGoogle Scholar
  55. Siest G, Roos F, Gabou JJ (1963) Dosage du NN dimethylbiguanide par le diacetyle en milieu alcalin. Bull Soc Pharm Nancy 58:29–38Google Scholar
  56. Sirtori CS. Franceschini G, Galli-Kienle M, Cighetti G, Galli G, Bondioli A (1978) Disposition of metformin (N,N-dimethylbiguanide) in man. Clin Pharmacol Ther 24(6):683–93PubMedGoogle Scholar
  57. Suzuki T, Kudo Y (1990) J Comput Aided Mol Design 4:155–158CrossRefGoogle Scholar
  58. Sayamal A (1975) Crystal data of biguanide dihydrochloride. Indian J Phys 49(9): 707–808Google Scholar
  59. Tanabe S, Kobayashi T, Kawanabe K (1987) Determination of oral hypoglycemic biguanides by high performance liquid chromatography with fluorescence detection. Anal Sci 3(l):69–73CrossRefGoogle Scholar
  60. Wellman KM, Harris DL, Murphy PJ (1967) Structure of mono, di, and tri protonated biguanides. Chem Commun:568–569Google Scholar
  61. Wickramasinghe JAF, Shaw SR (1972) Gas chromatographic behaviour of buformin hydrochloride, phenformin hydrochloride and phenylbiguanide. J Chromatogr 71:265–273PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • E. Prugnard
  • M. Noel

There are no affiliations available

Personalised recommendations